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 3 
Physical activity (PA) is a key element in Cystic Fibrosis (CF) treatment strategies, 4 
yet little is known as to whether activity compensation occurs. This study examined 5 
whether PA and/or sedentary time on one day were temporally associated with time 6 
spent in these intensities the following day in youth with CF. Time spent sedentary 7 
and in different PA intensities were objectively-measured for seven consecutive days 8 
in 50 youth (22 boys; 12.0±2.7 years); 25 with mild-to-moderate CF and 25 age- and 9 
sex-matched controls. Multilevel analyses (day and child) were conducted using 10 
generalised linear latent and mixed models. On any given day, every additional 10 11 
minutes spent in sedentary time or moderate-to-vigorous physical activity (MVPA) 12 
were associated with 1.9 (95%CI: -3.6 to -1.2) and 12.4 (95%CI: -22.1 to -2.9) 13 
minutes less sedentary time the following day, respectively. These temporal 14 
associations were also observed when split by group (3.1 vs. 1.9 minutes for healthy 15 
and CF, respectively). These findings indicate that youth do not compensate their PA, 16 
irrespective of disease status, between days, but may compensate their sedentary time 17 
between days. Experimental studies are warranted to fully elucidate whether 18 
compensatory responses to PA and sedentary time occur, which is fundamental for 19 
informing PA promotion strategies. 20 
 21 
Keywords: accelerometry; chronic disease; respiratory health; youth; paediatric 22 
23 
 3 
Introduction 24 
Cystic fibrosis (CF), currently affecting over 10,000 people in the UK (Cystic 25 
Fibrosis Trust, 2017), is the most prevalent inherited genetic disorder in the 26 
Caucasian population (Quinton, 1990). CF is a multi-system disease, which 27 
primarily affects the lungs and digestive system through mutations in the Cystic 28 
Fibrosis Transmembrane Conductance Regulator (CFTR) gene that lead to 29 
malfunctioning or absent CFTR proteins and impaired mucosal clearance 30 
mechanisms (Davies, Alton, & Bush, 2007; National Institute for Health and Care 31 
Excellence, 2017; Ratjen, 2009). Despite therapeutic advances and an increased life 32 
expectancy to 47 years for those born in 2017 (Cystic Fibrosis Trust, 2017), CF 33 
remains incurable, highlighting the need to enhance patient well-being. 34 
Regular participation in physical activity (PA) is an important component in 35 
the therapeutic management of individuals with CF (Williams & Stevens, 2013) and 36 
is recommended in internationally-recognised guidelines, irrespective of age or 37 
disease severity (Radtke, Nevitt, Hebestreit, & Kriemler, 2017; Smyth et al., 2014).  38 
In addition to the extensive benefits of leading an active lifestyle in healthy 39 
populations (Janssen & Leblanc, 2010), being active elicits further health benefits for 40 
those with CF (Hulzebos, Dadema, & Takken, 2013; National Institute for Health 41 
and Care Excellence, 2017; Radtke et al., 2017). Specifically, high levels of PA may 42 
lead to improved airway clearance by increasing transepithelial fluid transport and 43 
reduce, or even prevent, lung function decline (Schneiderman et al., 2014). 44 
Furthermore, PA and exercise improve aerobic capacity (Selvadurai et al., 2002), 45 
bone mineral density (Buntain et al., 2004), quality of life (Selvadurai, Blimkie, 46 
Cooper, Mellis, & Van Asperen, 2004), and ion channel function (Hebestreit, 47 
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Kersting, Basler, Jeschke, & Hebestreit, 2001), which not only improves mucus 48 
hydration and clearance, but reduces hospital admissions (Wilkes et al., 2007). 49 
Despite the benefits of PA for youth with CF, few engage in moderate-to-50 
vigorous physical activity (MVPA) for 60 minutes every day (Aznar et al., 2014; 51 
Mackintosh, Ridgers, Evans, & McNarry, 2018), highlighting the need to develop 52 
and implement population-specific PA intervention strategies. However, a significant 53 
challenge for CF multi-disciplinary teams is how to promote and encourage MVPA 54 
(Cox, Alison, & Holland, 2013) and how to ensure sustained behavior change is 55 
achieved. It has been hypothesised that even if interventions are successful at 56 
increasing children’s PA levels on one day, they may decrease their PA levels on 57 
subsequent days to compensate (i.e., the “activitystat” hypothesis; Dale, Corbin, & 58 
Dale, 2000; Rowland, 1998; Wilkin, Mallam, Metcalf, Jeffery, & Voss, 2006). Such 59 
compensation is thought to occur due to the central nervous system’s homeostatic 60 
regulation of total PA but the existence and nature of an activitystat in healthy 61 
populations has been debated (Gomersall, Rowlands, English, Maher, & Olds, 2013) 62 
and little is known about the presence of such behaviours in clinical populations. 63 
Specifically, as the activitystat may be considered a homeostatic mechanism, and 64 
given the treatment burden and elevated energetic costs in those with CF, one may 65 
postulate that they are more likely to display compensatory behaviours than their 66 
healthy counterparts (Ridgers, Barnett, et al., 2018). Indeed, even the set-point itself 67 
may differ to healthy counterparts, therefore, identifying compensatory behaviours 68 
could provide critical information for treatment strategies and on-going care.  69 
The aim of the current study was therefore to examine whether PA and 70 
sedentary time on one day are temporally associated with their activity levels on the 71 
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following day in children and adolescents with mild-to-moderate CF compared to 72 
age- and sex-matched healthy controls.  73 
 74 
Materials and Methods 75 
Participants 76 
Twenty-five children and adolescents aged 7 to 17 years with mild-to-moderate CF, 77 
confirmed by a sweat chloride >60 mmol·l−1 and genotyping (11 Homozygote; 14 78 
Heterozygote; 3 CF-related liver disease; 1 CF-related diabetes), were recruited from 79 
a UK CF outpatient clinic. Children with CF were eligible to participate if they had 80 
no increase in symptoms or weight loss two weeks prior to testing and had a stable 81 
lung function (defined as within 10% of their best in the previous six months). 82 
Unstable non-pulmonary comorbidities or acute infections warranted exclusion. All 83 
participants with CF were instructed to continue routine prescribed medications. 84 
Twenty-five age- and sex-matched apparently healthy counterparts were recruited 85 
from local schools. Ethical approval was granted by the Bromley NHS research 86 
ethics committee (REC reference: 13/LO/1907). Written informed consent and 87 
assent were obtained from parents/guardians and participants, respectively.  88 
 89 
Measures  90 
Anthropometry:  91 
Body mass (Seca 220; Hamburg, Germany) and standing and seated stature (Seca 92 
220; Hamburg, Germany) were measured to the nearest 0.01 kg and 0.01 m, 93 
respectively. Maturity offset was subsequently estimated as years from peak height 94 
velocity using the equations developed by Mirwald et al. (2002). For those with CF, 95 
all data was collected during a routine visit to the clinic; healthy age- and sex-96 
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matched counterparts were asked to attend one laboratory session. All measures were 97 
taken by trained staff using standardised procedures.   98 
 99 
Lung Function:  100 
Forced vital capacity (FVC) and forced expiratory volume in 1s (FEV1) were 101 
assessed using flow-volume loop spirometry (Vitalograph, UK), with the best of 102 
three consistent exhalations (<5% variability) used in further analyses. All 103 
participants were thoroughly familiarised with the manoeuvre and undertook practice 104 
attempts prior to those considered for inclusion. All lung function measurements 105 
were expressed as percentage predicted normal according to appropriate reference 106 
data (Stanojevic et al., 2009).  107 
 108 
Physical Activity and Sedentary Time:  109 
Physical activity and sedentary time were measured at 100 Hz using a hip-mounted 110 
ActiGraph GT3X+ accelerometer (ActiGraph LLC, Pensacola, FL). Participants 111 
were instructed to wear the monitor for seven consecutive days and advised to 112 
remove it for water-based activities (e.g., bathing, swimming) or contact sports. Data 113 
were downloaded using ActiLife software (v6.10.4; ActiGraph LLC), processed into 114 
15-second epochs, and reduced using a customised Excel macro. Non-wear time was 115 
defined as intervals with at least 20 minutes of consecutive zero’s, which is 116 
commonly used in youth studies examining compensation (Ridgers, Lamb, 117 
Timperio, Brown, & Salmon, 2018; Ridgers, Timperio, Cerin, & Salmon, 2015). 118 
Sedentary time was defined as 100 counts·min-1 (Ridgers et al., 2012), with time 119 
spent in moderate- (MPA; 4-5.99 METs) and vigorous-intensity (VPA; ≥6 METs) 120 
physical activity determined using age-adjusted cut-points (Freedson, Pober, & Janz, 121 
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2005). MPA and VPA were summed to obtain MVPA. Time spent in light-intensity 122 
physical activity (LPA) was defined as >100 counts·min-1 to the MPA cut-point. A 123 
valid day was defined as at least 9 hours of wear time. Participants with at least 3 124 
valid days of data, irrespective of week or weekend day, were included in the 125 
analyses (Mattocks et al., 2008).  126 
 127 
Statistical Analyses 128 
All statistical analyses were conducted using Stata SE v15 (StataCorp, Texas, USA). 129 
Independent t-tests were conducted to examine differences between participants who 130 
were included and excluded from the analyses and between the CF and healthy 131 
groups for all descriptive variables (mean ± SD).  132 
Multilevel analyses were performed using generalised linear latent and mixed 133 
models (GLLAMM). This approach accounted for the nested nature of the data 134 
arising from multiple days of accelerometer measurements within the same 135 
participant (Twisk, 2006). A two-level model was used in all analyses, namely day 136 
(level 1) and participant (level 2). GLLAMM was used to estimate associations 137 
between temporally adjacent values (i.e., pairs of days) for the outcome variables 138 
whilst adjusting for person-level (overall daily mean) sedentary time and/or PA, as 139 
appropriate. As GLLAMM can separate participant-level from day-level effects (i.e., 140 
within-person changes), these analyses are a more appropriate measure of 141 
compensatory changes (Ridgers, Timperio, Cerin, & Salmon, 2014). The analyses 142 
examined whether participants activity on one day (day d in the model) was 143 
associated with their activity from the previous day (day d-1 in the model). As data 144 
were collected over seven consecutive days, each participant provided a maximum of 145 
six data points for analysis. In all models, the random structure considered random 146 
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intercepts and slopes at the participant level. GLLAMMs were initially performed 147 
for the whole sample and adjusted for sex, age, day of measurement, group (CF and 148 
healthy), monitor wear time on a given day, and person-level PA and/or sedentary 149 
time, as appropriate. To examine whether these associations differed between 150 
groups, the analyses were subsequently performed for the CF and healthy groups 151 
separately. A two-tailed probability level of 0.05 was used for all analyses.  152 
 153 
Results 154 
Forty-three participants (24 boys, 19 girls; 21 CF, 22 healthy controls) met wear time 155 
criteria and were included in the analyses. There were no significant differences in 156 
the descriptive data of the included or excluded participants, and both CF and 157 
healthy participants engaged in similar levels of sedentary time and PA (Table 1). On 158 
average, participants provided 6.1 ± 0.9 valid days for analysis.  159 
 160 
****Table 1 near here**** 161 
 162 
The associations between temporally adjacent values for PA and sedentary 163 
time for the whole sample are shown in Table 2. On any given day, every additional 164 
10 minutes spent sedentary was associated with 2.1 minutes less sedentary time the 165 
following day (95% CI: -3.6 to -1.2). In contrast, on any given day, each additional 166 
10 minutes spent in MVPA was associated with 12.4 minutes less sedentary time the 167 
following day (95% CI: -22.1 to -2.9). 168 
 169 
****Table 2 near here**** 170 
 171 
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The associations between temporally adjacent values for PA and/or sedentary 172 
time for the healthy and CF groups are shown in Tables 3 and 4, respectively. Two 173 
statistically significant associations were observed for the healthy group, and one 174 
observed for the CF group. Specifically, on any given day, each additional 10 175 
minutes spent sedentary was associated with 3.1 (95% CI: -5.3 to -1.0) and 1.9 (95% 176 
CI: -3.6 to -0.3) minutes less sedentary time in the healthy and CF groups, 177 
respectively. Lastly, on any given day, each additional 10 minutes that participants in 178 
the healthy group engaged in MVPA was associated with 18.1 minutes less 179 
sedentary time the following day (95% CI: -33.8 to -2.4). 180 
 181 
****Tables 3 and 4 near here**** 182 
 183 
Discussion 184 
This study examined whether increased PA levels or sedentary time on any given 185 
day were temporally associated with these behaviours the following day in children 186 
and adolescents with CF and age- and sex-matched healthy controls. Youth, 187 
regardless of condition, do not appear to compensate for increased PA, of any 188 
intensity, but partially compensated for time spent being sedentary. Furthermore, 189 
findings suggest that increased MVPA on any given day was associated with 190 
decreased sedentary time the following day. However, this effect was not observed 191 
for those with CF when independent group models were utilised.  192 
No associations were found between time spent in PA on any given day and 193 
PA on a subsequent day, irrespective of intensity or condition. This suggests that 194 
youths do not compensate for increased PA levels on one day by decreasing their PA 195 
levels the following day. Whilst this is not consistent with the “activitystat” 196 
 10 
hypothesis (Rowland, 1998) and contrasts previous research that used the same 197 
analytical approach in healthy children (Ridgers, Barnett, et al., 2018; Ridgers et al., 198 
2014), the present findings are consistent with others who reported that healthy 199 
youths do not compensate between days (Baggett et al., 2010; Goodman, Mackett, & 200 
Paskins, 2011). Such discrepancies may, at least in part, be attributed to 201 
methodological differences in PA measurement analyses (e.g., wear time criteria), 202 
thereby limiting inter-study comparability. Nonetheless, a possible explanation may 203 
be that populations, or indeed individuals, compensate total PA levels in different 204 
ways, though there is a lack of consensus regarding the time frame over which this 205 
occurs. Specifically, some research suggests that youths can tolerate discrete bouts of 206 
activity (Ridgers, Lamb, et al., 2018), whilst others have demonstrated within-day 207 
compensation (Ridgers et al., 2015). Gomersall et al. (2013) contend that it is 208 
unlikely to be demonstrated on a day-to-day basis, citing previous interventions that 209 
have reported compensatory responses which ranged from approximately 1 to 3 210 
months, due to the period of the homeostatic regulatory response (Baggett et al., 211 
2010; Goodman et al., 2011). Indeed, it may be that compensatory effects take 212 
longer to emerge in clinical populations such as those with CF and that even the 213 
specific innate ‘set-point’ may vary between individuals depending on biological, 214 
psychosocial and physical environment-related factors (Eisenmann & Wickel, 2009; 215 
Rowland, 1998). It is also important to highlight that the intensity of physical 216 
activity may be a key determinant in whether compensatory responses are observed, 217 
although this remains to be elucidated, along with the potential interaction between 218 
an activitystat and health and environmental-related parameters. 219 
In this study, temporal associations were found between time spent in MVPA 220 
on any given day and time spent being sedentary the subsequent day. Specifically, 221 
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for every additional ten minutes spent in MVPA, children and adolescents engaged 222 
in 12.1 minutes less sedentary time the following day, although this was only 223 
statistically significant in the healthy youth. Whilst this may be a spurious finding as 224 
suggested in a previous study (Ridgers et al., 2014), if replicable, the current results 225 
refute the notion of a compensatory PA response, irrespective of clinical condition. 226 
In contrast, the present study suggests that youth may demonstrate a regulatory 227 
homeostatic mechanism for sitting time (i.e., a “sedostat”; Olds, Maher, Ridley, & 228 
Kittel, 2010). Specifically, for every ten additional minutes spent being sedentary on 229 
any given day, youth spent 2.1 minutes less time being sedentary the following day. 230 
Caution is required when interpreting this potential compensatory response given the 231 
small sample size and magnitude of the response. Furthermore, the day-to-day 232 
variability in sedentary time largely remains to be determined, although the limited 233 
evidence available appears to suggest that sedentary behaviours are fairly stable  234 
(Basterfield, Adamson, Pearce, & Reilly, 2011). However, it is nonetheless 235 
interesting to note that the magnitude of compensation was greater in healthy 236 
participants compared to those with CF. Given that previous research has questioned 237 
whether such homeostatic mechanisms are physiological or predominantly reflect 238 
environmental and sociological elements (Epstein, Paluch, Kilanowski, & Raynor, 239 
2004), the partial compensation in those with CF could be due to their high treatment 240 
burden, inhibiting time available for a greater compensatory response. It is therefore 241 
possible that the exhibited compensation may not be evidence of an activitystat, or 242 
even a sedostat, per se. Nonetheless, given that daily treatment duration remains 243 
relatively consistent, excluding treatment associated with exacerbations, it could be 244 
argued that activity opportunities for those with CF also remain constant. It could 245 
therefore be postulated that healthy populations are less tolerant to increased 246 
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sedentary time, or those with CF have a smaller relative amount of time to 247 
compensate. Future research is required to verify the apparent disease-related 248 
differences observed in the present study; future studies may wish to consider 249 
moderator analyses to help further elucidate these differences. 250 
Additionally, or perhaps alternatively, discrepancies between health 251 
conditions may be related to the cut-points used to define activity intensities. Whilst 252 
the cut-points utilised have demonstrated acceptable classification accuracy in youth 253 
(Trost, Loprinzi, Moore, & Pfeiffer, 2011), the lack of cut-points developed and 254 
validated for CF populations may have resulted in misclassifications of time spent in 255 
relative intensities (Mackintosh et al., 2018). However, it should be noted that there 256 
were no significant differences in PA levels between those with CF and their age- 257 
and sex-matched healthy controls. Indeed, 47.6% of our CF population met 258 
recommended guidelines, which is a considerably higher proportion than previously 259 
reported (Aznar et al., 2014). It could be speculated that greater compensatory 260 
responses would have been apparent in less active individuals, who may have a 261 
lower innate activitystat and thus an increase of 10 minutes MVPA would be a 262 
greater percentage of their overall daily activity levels. Alternatively, more active 263 
youth may have a greater tolerance around the ‘set-point’. However, Ridgers et al. 264 
(2018) found few variables which moderated such compensatory effects. Although 265 
research suggests that youths may be able to tolerate isolated increases in PA 266 
(Ridgers, Lamb, et al., 2018), the threshold required to trigger a compensatory 267 
response is presently unknown. It could be postulated that the reduced exercise 268 
capacity characteristic of the CF population may lower such a threshold, though 269 
further experimental work is required to identify the smallest meaningful 270 
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compensatory response. Such research should account for factors such as fitness and 271 
lung function (FEV1), which may moderate any compensatory responses.  272 
No other studies have investigated the activitystat hypothesis in those with 273 
CF, thereby precluding specific population comparisons. In healthy populations, the 274 
literature is dominated by observational studies, which have reported mixed findings; 275 
few experimental studies have been conducted. This lack of consensus regarding 276 
compensatory changes may be explained, at least in part, by inter-study 277 
methodological differences, including, but not limited to, previous studies failing to 278 
account for person-level variation in responses. Indeed, Selvadurai et al. (2004) 279 
reported significant influences of maturity on PA levels in those with CF, and a 280 
failure to account for this, as well as disease severity, may limit interpretation. 281 
Nonetheless, the concept of a biological control of PA and the activitystat for those 282 
with CF has significant implications; given the numerous additional health benefits 283 
for those with CF (National Institute for Health and Care Excellence, 2017; 284 
Schneiderman et al., 2014), over and above those identified in healthy children 285 
(Janssen & Leblanc, 2010), the present study highlights that it may be feasible to 286 
increase total physical activity without compensatory responses to discrete bouts of 287 
PA.  288 
The present findings have potential implications for the development and 289 
delivery of PA interventions for youth with CF. Whilst specific PA and exercise 290 
recommendations remain in their infancy, HIIT has been specifically identified as a 291 
potential strategy to enhance PA levels in those with CF (Cox & Holland, 2017). 292 
However, Kriemler et al. (1999) suggest that high-intensity exercise may be 293 
associated with compensation when other intensities are not, questioning the 294 
potential applicability of this exercise modality to increasing overall physical activity 295 
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levels.  Future studies should therefore specifically examine whether compensation 296 
occurs as a result of participating in prescribed PA or exercise interventions and its 297 
interaction with exercise intensity. Moreover, such research should seek to measure 298 
total energy expenditure, as well as total PA levels, as, whilst PA is likely to be the 299 
predominant contributory factor to total energy expenditure, it could be argued that 300 
disease severity may have significant implications on energy expenditure. Indeed, 301 
Gomersall et al. (2013) identified that researchers should clearly distinguish between 302 
an ‘activitystat’ and ‘energystat’. 303 
This is the first study to examine compensatory changes in objectively-304 
measured PA levels and sedentary time between days in children and adolescents 305 
with CF. Nonetheless, several limitations should be acknowledged and the present 306 
results should be interpreted with caution. Specifically, this study was observational 307 
in nature; future experimental research should aim to increase or decrease PA during 308 
specific periods of inactivity or activity, respectively, to ascertain if, and indeed 309 
when, compensatory effects occur (Ridgers, Lamb, et al., 2018). The sample size 310 
also restricted the number of person-level variables that could be investigated, which 311 
may potentially moderate the compensatory effect (Ridgers, Barnett, et al., 2018). 312 
Furthermore, given that no CF-specific cut-points are currently available, those 313 
developed for healthy children were applied to those with CF. This may have 314 
resulted in the misclassification of sedentary time and activity intensities which 315 
limits the interpretation of the present results. It is also pertinent to note that further 316 
research is required to identify the duration required to classify as clinically 317 
meaningful compensatory behaviour. 318 
 319 
Conclusions 320 
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In conclusion, these findings are inconsistent with the activitystat hypothesis, 321 
regardless of population. However, youth may compensate for sedentary time, albeit 322 
to a lesser extent in those with CF. These findings highlight that it may be possible to 323 
enhance PA levels in youth CF populations, without concomitant increases in 324 
deleterious sedentary time.  325 
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Table 1: Participant characteristics and activity levels (mean ± SD)  468 
 Whole Sample 
n = 43 
Cystic Fibrosis 
n = 21 
Healthy Controls  
n = 22 
Participant 
Characteristics 
   
Age (years) 11.9 ± 2.6 12.1 ± 2.6 11.7 ± 2.7 
Stature (cm) 147.4 ± 13.7 146.0 ± 13.5 148.8 ± 14.1 
Body mass (kg) 43.0 ± 12.6 41.9 ± 11.5 44.1 ± 13.7 
BMI (kg·m-2) 19.3 ± 3.2 19.3 ± 2.8 19.4 ± 3.6 
Maturity Offset (yrs) -1.04 ± 2.3 -1.04 ± 2.4 -1.04 ± 2.3 
FVC (% predicted)  85 ± 13 82 ± 12 88 ± 14 
FEV1 (% predicted) 86 ± 13 80 ± 10 92 ± 14 
    
ActiGraph Data    
Sedentary time 
(min·day-1) 
566.4 ± 65.3 555.8 ± 59.9 576.5 ± 69.9 
LPA (min·day-1) 222.9 ± 50.8 225.5 ± 50.4 220.6 ± 52.3 
MVPA (min·day-1) 60.7 ± 33.4 58.9 ± 36.9 62.2 ± 30.3 
Wear time (min·day-
1) 
848.6 ± 44.0 840.3 ± 48.9 856.7 ± 38.2 
FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.  469 
  470 
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Table 2: Associations between time (min) spent in different physical activity 471 
intensities and sedentary time variables between pairs of days (all participants; 472 
n=43) 473 
 Between-days modela 
 b (95% CI) p value 
SEDD1 → SEDD2 -0.24 (-0.36 to -0.12) <0.001 
LPAD1→ LPAD2 -0.05 (-0.20 to 0.11) 0.57 
MVPAD1 → MVPAD2 -0.01 (-0.49 to 0.47) 0.96 
SEDD1 → LPAD2 0.01 (-0.09 to 0.09) 0.97 
SEDD1 → MVPAD2 0.02 (-0.04 to 0.08) 0.61 
LPAD1 → SEDD2 -0.20 (-0.42 to 0.03) 0.08 
LPAD1 → MVPAD2 0.03 (-0.09 to 0.14) 0.68 
MVPAD1 → SEDD2 -1.24 (-2.21 to -0.29) 0.01 
MVPAD1 → LPAD2 -0.12 (-0.76 to 0.53) 0.72 
aAnalyses adjusted for: sex, decimal age, condition, measurement day, wear time, 474 
person-level physical activity and/or sedentary time 475 
  476 
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Table 3: Associations between time (min) spent in different physical activity 477 
intensities and sedentary time variables between pairs of days  (healthy 478 
matched controls) 479 
 Between-days modela 
 b (95% CI) p value 
SEDD1 → SEDD2 -0.31 (-0.53 to -0.10) <0.01 
LPAD1→ LPAD2 0.11 (-0.15 to 0.37) 0.40 
MVPAD1 → MVPAD2 -0.23 (-1.02 to 0.57) 0.58 
SEDD1 → LPAD2 0.11 (-0.04 to 0.25) 0.15 
SEDD1 → MVPAD2 -0.01 (-0.13 to 0.09) 0.81 
LPAD1 → SEDD2 -0.31 (-0.70 to 0.09) 0.13 
LPAD1 → MVPAD2 -0.03 (-0.23 to 0.17) 0.77 
MVPAD1 → SEDD2 -1.81 (-3.38 to -0.24) 0.02 
MVPAD1 → LPAD2 0.56 (-0.48 to 1.59) 0.29 
aAnalyses adjusted for: sex, age, measurement day, wear time, person-level physical 480 
activity and/or sedentary time 481 
  482 
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Table 4: Associations between time (min) spent in different physical activity 483 
intensities and sedentary time variables between pairs of days  (CF patients) 484 
 Between-days modela 
 b (95% CI) p value 
SEDD1 → SEDD2 -0.19 (-0.36 to -0.03) 0.02 
LPAD1→ LPAD2 -0.10 (-0.30 to 0.10) 0.33 
MVPAD1 → MVPAD2 0.25 (-0.37 to 0.86) 0.43 
SEDD1 → LPAD2 -0.43 (-0.16 to 0.07) 0.46 
SEDD1 → MVPAD2 0.04 (-0.04 to 0.12) 0.38 
LPAD1 → SEDD2 -0.14 (-0.42 to 0.15) 0.36 
LPAD1 → MVPAD2 0.06 (-0.08 to 0.21) 0.41 
MVPAD1 → SEDD2 -1.01 (-2.27 to 0.24) 0.11 
MVPAD1 → LPAD2 -0.38 (-1.23 to 0.46) 0.38 
aAnalyses adjusted for: sex, age, measurement day, wear time, person-level physical 485 
activity and/or sedentary time 486 
 487 
